OPG/RANK/RANKL Single-Nucleotide Polymorphisms in Rheumatoid Arthritis: Associations with Disease Susceptibility, Bone Mineral Density, and Clinical Manifestations in a Chinese Han Population
Abstract
Objective The osteoprotegerin (OPG)/receptor activator of nuclear factor-κB (RANK)/receptor activator of nuclear factor-κB ligand (RANKL) system plays a pivotal role in the balance between osteoblasts and osteoclasts and is closely related to the pathogenesis of rheumatoid arthritis (RA). The present study aimed to clarify the associations of OPG/RANK/RANKL gene single-nucleotide polymorphisms (SNPs) with disease susceptibility, bone mineral density (BMD), and clinical manifestations in RA patients. Methods A case-control study including 319 RA patients and 330 healthy controls was conducted. All subjects were genotyped for rs4355801 and rs1023968 in OPG, rs10805033 in RANK, and rs9533155 and rs875625 in RANKL. BMD and clinical manifestations were recorded. Results An association was found between OPG rs4355801 and risk of RA. In recessive models, the GG genotype of rs4355801 was associated with an increased risk of RA compared with the AA/AG genotypes (OR=1.679, 95% CI: 1.062–2.655, p=0.025). A correlation between RANKL rs9533155 and BMD was found in RA patients. Patients with the GG genotype (n=108) in RANKL rs9533155 had the more decreased BMD values at lumbar level 2 (t=3.424, p=0.009), lumbar level 3 (t=3.171, p=0.019), lumbar level 4 (t=4.187, p=0.001), and total lumbar levels 2–4 (t=2.989, p=0.021) compared with CC+GC genotypes. No associations were found between the OPG, RANK, and RANKL SNPs and clinical manifestations of RA (all p>0.05). Logistic regression analysis…
How strong is the evidence?
Evidence Hub reads this as a case-control. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 319 participants or records.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.